CISD2 ensures adequate ER-mitochondrial coupling, critically supporting mitochondrial function in neurons
Loss of Cisd2, an iron-sulfur cluster transfer protein, results in type 2 Wolfram syndrome (WS2), a disorder associated with severe impacts on pancreatic β cell and neuronal functions. Cisd2 has been implicated in regulating intracellular Ca<sup>2+</sup> signaling. However, the molecular basis and cellular consequences remain poorly understood. In this work, we demonstrate that Cisd2 intersects with intracellular Ca<sup>2+</sup> dynamics at different levels, by interacting with the inositol-1,4,5-trisphosphate receptors and as a regulator of ER-mitochondria tethering. As such, loss of Cisd2 in HeLa cells results in reduced ER-mitochondrial Ca<sup>2+</sup> transfer while only modestly impacting cytosolic Ca<sup>2+</sup> signaling. In HeLa cells, Cisd2 deficiency promotes autophagic flux, yet has minimal impact on mitochondrial function. However, studying the impact of Cisd2 deficiency in human induced pluripotent stem cell -derived cortical neurons revealed a severe loss of glutamate-evoked Ca<sup>2+</sup> responses in cytosol and associated uptake in mitochondria due to loss of ER-mitochondria contact sites. Correlating with the profound changes in cellular Ca<sup>2+</sup> handling, mitochondrial function (oxygen consumption rate, ATP production, mitochondrial potential maintenance) declined severely, while autophagic flux was increased. Overall, these deficiencies further impact the resilience of Cisd2-deficient cortical neurons to cell stress as Cisd2-KO neurons were highly sensitive to staurosporine, an inducer of apoptosis. Overall, this work is one of the first to decipher the impact of Cisd2 on ER-mitochondria Ca<sup>2+</sup> handling in a WS2 disease-relevant cell models, thereby revealing a unique dependence of neurons on Cisd2 for their mitochondrial health and cell stress resilience.
Authors
- Karan Ahuja (ORCID: https://orcid.org/0000-0003-2497-0530)
- Annika Vaarmann (ORCID: https://orcid.org/0000-0003-0296-8325)
- Geert Bultynck (ORCID: https://orcid.org/0000-0002-5968-4828)
- Catherine M. Verfaillie (ORCID: https://orcid.org/0000-0001-7564-4079)
- Tim Vervliet (ORCID: https://orcid.org/0000-0002-4030-5875)
- Guizhen Fan (ORCID: https://orcid.org/0000-0002-6741-6989)
- Martijn Kerkhofs (ORCID: https://orcid.org/0000-0003-2497-9244)
- Jens Loncke (ORCID: https://orcid.org/0000-0002-8703-9009)
- Ian de Ridder (ORCID: https://orcid.org/0000-0001-6410-3066)
- Irina I. Serysheva (ORCID: https://orcid.org/0000-0001-6266-3422)
- Jan B. Parys (ORCID: https://orcid.org/0000-0002-3591-4967)
- Allen Kaasik (ORCID: https://orcid.org/0000-0002-4850-3198)
- Rita La Rovere
Institutions
- Rega Institute for Medical Research (BE)
- The University of Texas Health Science Center (US)
- University of Tartu (EE)
- KU Leuven (BE)
Publication Details
- Journal
- Acta Neuropathologica Communications
- Published
- 2025-11-26
- DOI
- https://doi.org/10.1186/s40478-025-02132-7
- Citations
- 1
- Primary Topic
- Metalloenzymes and iron-sulfur proteins
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- American Heart Association
- Hope Foundation
- Eesti Teadusagentuur
- Fonds Wetenschappelijk Onderzoek
- KU Leuven
- Vlaamse regering
- National Institutes of Health